ÖZGEÇMİŞ. 1. Adı Soyadı: Tayfun Açıl 2. Doğum Tarihi: Unvanı: Profesör
|
|
- Elizabeth Hamilton
- 8 years ago
- Views:
Transcription
1 ÖZGEÇMİŞ 1. Adı Soyadı: Tayfun Açıl 2. Doğum Tarihi: Unvanı: Profesör 4. Öğrenim Durumu: Derece Alan Üniversite Lisans Tıp Doktoru Hacettepe Üniversitesi Tıp Fakültesi (İngilizce) Y. Lisans Kardiyoloji Uzmanı Hacettepe Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı Doktora Kardiyoloji Doçenti Başkent Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı Yıl Kardiyoloji Profesörü Yeni Yüzyıl Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı 2015 Yüksek Lisans Tez Başlığı ve Tez Danışmanı: Kronik iskemik kalp hastalarında egzersizin fibrinolitik ve koagülasyon sistemine etkisi, Prof. Dr. Serdar Aksöyek Akademik Unvanlar: Doçent 2007, Profesör 2015 Yayınlar 7.1. Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities) A1. Tokgozoglu, S.L., T. Acil, I.C. Haznedaroglu, K. Aytemir ve M.K. Batur, Thrombosis involving the major veins with heterozygote factor V Leiden mutation as the only risk factor, Clin. Appl. Thromb. Hemost., 5, (1999). 1
2 A2. Batur, M.K., T. Acil, O. Onalan, A. Yildirir, K. Ovunc, G. Kabakci, A. Oto, H. Ozkutlu, N. Nazli, G. Gursel ve S. Kes, Is ventricular repolarization heterogeneity a cause of serious ventricular tachyarrhythmias in aortic valve stenosis?, Clin. Cardiol., 23, (2000). A3. Ozer, N., K. Aytemir, E. Atalar, E. Sade, S. Aksoyek, K. Ovunc, T. Acyl, N. Nazly, F. Ozmen, A. Oto ve S. Kes, P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation, Pacing Clin. Electrophysiol., 23, (2000). A4. Atalar, E., T. Acil, K. Aytemir, N. Ozer, K. Ovunc, S. Aksoyek, S. Kes ve F. Ozmen, Acute anterior myocardial infarction following a mild nonpenetrating chest trauma a case report, Angiology, 52, (2001). A5. Kabakci, G., O. Onalan, M.K. Batur, A. Yildirir, R. Cagrikul, T. Acil, L. Tokgozoglu, A. Oto, F. Ozmen ve S. Kes, What is the optimal evaluation time of the QT dispersion after acute myocardial infarction for the risk stratification?, Angiology, 52, (2001). A6. Ozmen, F., E. Atalar, K. Aytemir, N. Ozer, T. Acil, K. Ovunc, S. Aksoyek ve S. Kes, Effect of balloon-induced acute ischaemia on P wave dispersion during percutaneous transluminal coronary angioplasty, Europace, 3, (2001). A7. Atalar, E., T. Acil, K. Aytemir, I. Haznedaroglu, N. Ozer, H. Kilic, G. Kuru, S. Aksoyek, K. Ovunc, S. Kes, S. Kirazli ve F. Ozmen, Diminished global fibrinolytic capacity in patients with mitral valve prolapse is associated with transient ischemic attacks, Clin. Appl. Thromb. Hemost., 8, (2002). A8. Atalar, E., F. Ozmen F, I. Haznedaroglu, T. Acil, N. Ozer, K. Ovunc, S. Aksoyek ve S. Kes, Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and slselectin and sfas levels in hyperlipidemic patients with coronary artery disease, Int. J. Cardiol., 84, (2002). 2
3 A9. Alikasifoglu, M., L. Tokgozoglu, T. Acil, E. Atalar, M. Ali Oto, S. Sirri Kes, E. Tuncbilek, Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyopathy, Eur. J. Heart Fail., 5, (2003). A10. Esinler, I., N. Yigit, A. Ayhan, S. Kes, K. Aytemir ve T. Acil, Coronary artery dissection during pregnancy, Acta Obstet. Gynecol. Scand., 2003, 82, (2003). A11. Atalar, E., I.C. Haznedaroglu, T. Acil, N. Ozer, H. Kilic, K. Ovunc, S. Aksoyek, N. Nazli, S. Kes, G. Kabakci, S. Kirazli ve F. Ozmen, Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia, Platelets, 14, (2003). A12. Wichter, T., M. Paul, C. Wollmann, T. Acil, P. Gerdes, O. Ashraf, T.D. Tjan, R. Soeparwata, M. Block, M. Borggrefe, H.H. Scheld, G. Breithardt ve D. Bocker, Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: singlecenter experience of long-term follow-up and complications in 60 patients, Circulation, 109, (2004). PROFESÖRLÜK ANA YAYIN A13. Acil, T., T. Wichter, J. Stypmann, F. Janssen, M. Paul, M. Grude, H.H. Scheld, G. Breithardt ve C. Bruch, Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure, Int. J. Cardiol., 103, (2005). A14. Paul, M., M. Schafers, P. Kies, T. Acil, K. Schafers, G. Breithardt, O. Schober ve T. Wichter, Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation, Eur. J. Nucl. Med. Mol. Imaging, 33, (2006). A15. Acil, T., R. Turkoz, M. Acil, A.T. Sezgin, M. Baltali, O. Gulcan, B. Ozin ve H. Muderrisoglu, Value of Prolonged QRS Duration as a Predictor of Low Cardiac Output 3
4 Syndrome in Patients With Impaired Left Ventricular Systolic Function Who Undergo Isolated Coronary Artery Bypass Grafting, Am. J. Cardiol., 98, (2006). A16. Colkesen, A.Y., M. Baltali, T. Acil, G. Tekin, A. Tekin, T. Erol, A.T. Sezgin ve H. Muderrisoglu, Coronary and systemic stent embolization during percutaneous coronary interventions: a single center experience, Int. Heart J., 48, (2007). A17. Acil, T., E. Atalar, L. Sahiner, B. Kaya, I.C. Haznedaroglu, L. Tokgozoglu, K. Ovunc, K. Aytemir, N. Ozer, A. Oto, F. Ozmen, N. Nazli, S. Kes ve S. Aksoyek, Effects of acute exercise on fibrinolysis and coagulation in patients with coronary artery disease, Int. Heart J., 48, (2007) A18. Colkesen, Y., T. Acil, S. Demircan, A.T. Sezgin, B. Ozin ve H. Muderrisoglu, Echocardiographic features of patients with paroxysmal atrial fibrillation, Int. J. Cardiovasc. Imaging., 2007 (elektronik yayın). A19. Range, F.T., M. Schafers, T. Acil, K.P. Schafers, P. Kies, M. Paul, S. Hermann, B. Brisse, G. Breithardt, O. Schober ve T. Wichter, Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation, Eur. Heart J., 28, (2007). A20. Atar, I., T. Acil ve B. Ozin, Reel syndrome in a patient with a three-chamber implantable cardiovertor-defibrillator, Europace,9,674 (2007). A21. Acil,T. Y. Colkesen, R. Turkoz, A.T. Sezgin, M. Baltali, O. Gulcan, S. Demircan, A. Yildirir, B. Ozin ve H. Muderrisoglu, Value of Preoperative Echocardiography in the Prediction of Postoperative Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting, Am. J. Cardiol.,100, (2007). A22. Yerdelen, D., Acil,T., B. Goksel, M. Karatas, Heart rate recovery in migraine and tension-type headache, Headache.,48:221-5 (2008). 4
5 A23. Colkesen, A.Y., O. Sen, S. Giray, T. Acil, B. Ozin, H. Muderrisoglu, Correlation between QTc interval and clinical severity of subarachnoid hemorrhage depends on the QTc formula used, Pacing Clin. Electrophysiol.,30, (2007). A24. Yerdelen, D., T. Acil, B. Goksel, M. Karataş, Autonomic function in tension-type headache, Acta Neurol. Belg.,107, (2007). A25. Colkesen, Y., T. Acil, B. Abayli, F. Yigit, T. Katircibasi, T. Kocum, S. Demircan, A. Sezgin, B. Ozin, H. Muderrisoglu, Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation?, Blood Coagul. Fibrinolysis,19,411-4 (2008). A26. Colkesen, A.Y., T. Acil, S. Demircan, A.T. Sezgin, H. Muderrisoglu, Coronary lesion type, location, and characteristics of acute ST elevation myocardial infarction in young adults under 35 years of age, Coron. Artery Dis.,19,345-7 (2008). A27. Range, F.T., M. Paul, K.P. Schäfers, T. Acil, P. Kies, S. Hermann, O. Schober, G. Breithardt, T. Wichter, M.A. Schäfers, Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation, J. Nucl. Med., 50, [Epub ahead of print] (2009). A28. Cölkesen, Y., T. Acil, A. Findikçioğlu, A. Tekin, D. Kiliç, B. Ozin, H. Müderrisoğlu, Tissue Doppler evaluation of the effects of major lung resection on cardiac functions, Turk Kardiyol Dern Ars., 37, (2009). Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılanbildiriler B1. Batur, M.K., T. Acil, R. Cagrikul, G. Kabakci, K. Ovunc, S. Aksoyek, F. Ozmen, A. Oto, N. Nazli ve S. Kes, What is the optimal evaluation time of the risk stratification after acute 5
6 myocardial infarction with the QT dispersion?, XIth World Symposium on Cardiac Pacing and Electrophysiology, Berlin, 1999,Pacing Clin. Electrophysiol., 6 (Pt 2), A19 (1999). B2. Ozer, N., K. Aytemir, E. Atalar, K. Ovunc, S. Aksoyek, E. Sade, T. Acil, L. Tokgozoglu, N. Nazli ve S. Kes, Abnormal left ventricular long axis function in patients with rheumatic mitral stenosis, 4th Annual and Plenary Meeting of the Working Group on Echocardiography of the European Society of Cardiology, Lisbon, 2000, Eur J Echocardiography, 1 (suppl 2), S104 (2000). B3. Oto, A., T. Acil, M.K. Batur, A. Yildirir, L. Tokgozoglu, G. Kabakci, S. Aksoyek, K. Aytemir, K. Ovunc, F. Ozmen ve H. Ozkutlu, Is there a diurnal variation in the distribution of spontaneous ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator, 9th Congress of the International Society for Holter and Noninvasive Electrocardiology & International Congress on Cardiac Pacing and Electrophysiology, İstanbul, 2000, Ann. Noninvasive Electrocardiol., 5 (Pt 2), S40 (2000). B4. Oto, A., M.K. Batur, A. Yildirir, T. Acil, O. Onalan, K. Aytemir, E. Atalar, L. Tokgozoglu, G. Kabakci, S. Aksoyek ve K. Ovunc, Combined use of manuel traction, snares, and excimer laser techniques fort he extraction of pacemaker or ICD leads: the Hacettepe experience, 9th Congress of the International Society for Holter and Noninvasive Electrocardiology & International Congress on Cardiac Pacing and Electrophysiology, İstanbul, 2000, Ann. Noninvasive Electrocardiol., 5 (Pt 2), S38 (2000). B5. Ozer, N., K. Aytemir, S. Aksoyek, O. Ozcebe, E. Atalar, T. Acil, K. Ovunc, F. Ozmen, S. Kes ve A. Oto, Is there any relation between increased QT dispersion and ventricular arrhythmias in patients with Behçet s disease?, 9th Congress of the International Society for Holter and Noninvasive Electrocardiology & International Congress on Cardiac Pacing and Electrophysiology, İstanbul, 2000, Ann. Noninvasive Electrocardiol., 5 (Pt 2), S33 (2000). 6
7 B6. Ozer, N., K. Aytemir, I. Can, E. Atalar, T. Acil, S. Aksoyek, K. Ovunc, H. Ozkutlu, N. Nazli, F. Ozmen, S. Kes ve A. Oto, Prognostic value of the tombstoning ECG pattern and its relation to angiographic findings and QT dispersion in patients with acute myocardial infarction, 9th Congress of the International Society for Holter and Noninvasive Electrocardiology & International Congress on Cardiac Pacing and Electrophysiology, İstanbul, 2000, Ann. Noninvasive Electrocardiol., 5 (Pt 2), S2 (2000). B7. Wichter, T., M. Paul, C. Wollmann, T. Acil, D. Hammel, J. Rötker ve D. Böcker, Implantierbarer Kardioverter-Defibrillator bei arrhythmogener rechtsventrikulärer Kardiomyopathie: Akutergebnisse, Komplikationen und Langzeitverlauf, 69. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Mannheim, 2003, Z. Kardiol., 92 (Supp 1), I/8 (2003). B8. Wichter, T., M. Paul, T. Acil, P. Gerdes ve G. Breithardt, Katheterablation ventrikulärer Tachykardien bei Patienten mit arrhythmogener rechtsventrikulärer Kardiomyopathie: was ist erreichbar und was bleibt?, 69. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Mannheim, 2003, Z. Kardiol., 92 (Supp 1), I/379 (2003). B9. Wichter, T., M. Meyborg, M. Paul, T. Fobker, J. Neumann, T. Acil, P. Boknik ve G. Breithardt, Arrhythmogenic right ventricular cardiomyopathy: depletion of presynaptic norepinephrine provides further evidence for cardiac autonomic dysfunction, XXV Congress of the European Society of Cardiology, Vienna, 2003, Eur. Heart J., 24 (suppl), 497 (2003). B10. Wichter, T., P. Kies, T. Acil, L. Eckardt, L. Stegger, M. Paul, K.P. Schafers, O. Schober, E. Schulze-Bahr ve M.A. Schafers, Autonomic dysfunction in Brugada syndrome: new evidence for enhanced presynaptic norepinephrine recycling and subsequent reduction of adrenergic myocardial stimulation, American Heart Association Scientific Sessions, 2003, Orlando, Circulation, 108 (Supp), IV-475 (2003). 7
8 B11. T. Acil, T. Wichter, J. Stypmann, F. Janssen, M. Paul, M. Grude, H.H. Scheld, G. Breithardt ve C. Bruch, The Ratio of Early Diastolic Mitral Flow Velocity to Early Diastolic Mitral Annular Velocity Predicts Prognosis in Patients With Chronic Congestive Heart Failure, American College of Cardiology 53rd Annual Scientific Session, New Orleans, 2004, J. Am. Coll. Cardiol., 43 (5), 346A (2004). B12. Wichter, T., M. Meyborg, M. Paul, M. Fobker, J. Neumann, T. Acil, P. Boknik, P. Gerdes ve G. Breithardt, Entleerte Noradrenalin-Speicher im Myokard belegen eine kardiale autonome Dysfunktion bei arrhythmogener rechtsventrikulärer Kardiomyopathie, 70. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Mannheim, 2004, Z. Kardiol., 93 (Supp 3), III/156 (2004). B13. Meyborg, M., J. Neumann, M. Paul, L. Eckardt, T. Acil, P. Boknik, P. Gerdes, M. Fobker ve T. Wichter, Autonome Dysfuntion bei Brugada-Syndrom: Neue Befunde einer reduzierten adrenergen Stimulation des Myokards aus biochemischen Analysen von Endomyokardbiopsien, 70. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herzund Kreislaufforschung, Mannheim, 2004, Z. Kardiol., 93 (Supp 3), III/165 (2004). B14. T. Acil, R. Turkoz, M. Acil, A.T. Sezgin, M. Baltali, O. Gulcan, B. Ozin ve H. Muderrisoglu, Prolonged QRS duration is a significant predictor of low cardiac output syndrome development after isolated coronary artery bypass grafting in patients with impaired left ventricular systolic dysfunction, American Heart Association Scientific Sessions, 2006, Chicago, Circulation, 114 (Supp), II-658 (2006). B15. Batur, M.K., T. Acil, O. Onalan, A. Yildirir, K. Ovunc, G. Kabakci, A. Oto, H. Ozkutlu, N Nazli, G. Gursel ve S. Kes, Is ventricular repolarization heterogeneity a cause of serious ventricular tachyarrhythmias in aortic valve stenosis?, XIth World Symposium on Cardiac Pacing and Electrophysiology, Berlin, 1999, Pacing Clin. Electrophysiol., 6 (Pt 2), A40 (1999). 8
9 B16. Özmen, F., E. Atalar, K. Aytemir, N. Özer, T. Acil, S. Aksöyek, K. Övünç ve S. Kes, P wave dispersion in patients with percutaneous coronary angioplasty-induced myocardial ischemia, 12th International Congress, Nice, 2000, Europace, 1, 188P/8 (2000). B17. Aytemir, K., E. Atalar, T. Acil, N. Özer, S. Aksöyek, K Övünç, A. Oto, F. Özmen ve S. Kes, Effect of spontaneous myocardial ischemia on QT dispersion in patients with coronary artery disease, XXII Congress of the European Society of Cardiology, Amsterdam, 2000, Eur. Heart J., 21 (suppl), 520 (2000). B18. Atalar, E., K. Aytemir, I. Haznedaroglu, T. Acil, N. Ozer, K. Ovunc, S. Aksoyek, S. Kes, N. Nazly ve F. Ozmen, Decreased fibrinolytic capacity in rheumatic mitral stenosis, XXIII Congress of the European Society of Cardiology, Stockholm, 2001, Eur. Heart J., 22 (suppl), 311 (2001). B19. Atalar, E., T. Acil, K. Aytemir, I. Haznedaroglu, N. Ozer, S. Aksoyek, K. Övünç, S. Kes ve F. Ozmen, Impaired Fibrinolytic Capacity in Rheumatic and Non-rheumatic Atrial Fibrillation, American College of Cardiology 50th Annual Scientific Session, Orlando, 2001, J. Am. Coll. Cardiol., 37 (2), 648A (2001). B20. Atalar, E., T. Acýl, K. Aytemir, I. Haznedaroglu, N. Özer, A. Daver, K. Övünç, S. Aksöyek, S. Kes ve F. Özmen, Effects of Atorvastatin Treatment on Global Fibrinolytic Capacity, Apoptosis, and Leukocyte Activation in Patients With Coronary Artery Disease, American College of Cardiology 50th Annual Scientific Session, Orlando, 2001, J. Am. Coll. Cardiol., 37 (2), 648A (2001). B21. T. Acil, E. Atalar, L. Sahiner, B. Kaya, L. Tokgözoglu, K. Övünc, S. Kirazli, I. Haznedaroglu, S. Kes ve S. Aksöyek, Effects of Acute Exercise on the Fibrinolytic and Coagulative System in Patients With Chronic Ischemic Heart Disease, American College of 9
10 Cardiology 52th Annual Scientific Session, Chicago, 2003, J. Am. Coll. Cardiol., 41 (6), 178A (2003). B22. Wichter, T., P. Kies, M. Paul, T. Acil, K. Schafers, O. Schober, G. Breithardt, P.G. Camici ve M. Schafers, Störung der präsynaptischen autonomen Innervation des Myokards bei Patienten mit Brugada-Syndrom, 69. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Mannheim, 2003, Z. Kardiol., 92 (Supp 1), I/353 (2003). B23. Paul, M., M. Schafers, P. Kies, M. Grude, T. Acil, D. Bocker, O. Schober ve T. Wichter T, Sympathische Innervation und ventrikuläre Tachyarrhythmien im Langzeitverlauf bei Patienten mit idiopathischem Kammerflimmern, 27. Herbsttagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Münster, 2003, Z. Kardiol., 92 (Supp 2), II/13 (2003). B24. T. Acil, F.T. Range, M. Schafers, P. Kies, K. Schafers, M. Meyborg, O. Schober ve T. Wichter, Gestörte endothelunabhängige myokardiale Perfusionsreserve bei Patienten mit Vorhofflimmern- eine quantitative Studie mittels Positronen-Emissionstomographie und radioaktiv markiertem Wasser (H 2 O 15 ), 27. Herbsttagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Münster, 2003, Z. Kardiol., 92 (Supp 2), II/91 (2003). B25. T. Acil, C. Bruch, J. Stypmann, G. Breithardt ve T. Wichter, Prognostic value of new Doppler echocardiographic parameters- implications for risk stratification in patients with chronic congestive heart failure, 27. Herbsttagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Münster, 2003, Z. Kardiol., 92 (Supp 2), II/104 (2003). 10
11 B26. Range, F.T., T. Acil, M. Schaefers, P. Kies, O. Schober ve T. Wichter T, Atrial Fibrillation Reduces Endothelium-Independent Myocardial Perfusion Reserve: A Quantitative Study Using Positron Emission Tomography, American College of Cardiology 53rd Annual Scientific Session, New Orleans, 2004, J. Am. Coll. Cardiol., 43 (5), 337A (2004). B27. Wichter, T., M. Meyborg, M. Paul, J. Neumann, T. Acil, P. Boknik, M. Fobker, P. Gerdes ve G. Breithardt G, Autonomic Dysfunction in Brugada Syndrome: New Evidence for Impaired Adrenergic Stimulation from Biochemical Analyses of Endomyocardial Biopsies, NASPE-Heart Rhythm 2004 Scientific Sessions, 2004, San Francisco,Annual Scientific Sessions Meeting Abstracts, 389 (2004). B28. Wichter, T., M. Meyborg, M. Paul, M. Fobker, J. Neumann, T. Acil, P. Boknik, P. Gerdes ve G. Breithardt, Arrhythmogenic Right Ventricular Cardiomyopathy: Depletion of Presynaptic Norepinephrine Provides Further Evidence for Cardiac Autonomic Dysfunction, NASPE-Heart Rhythm 2004 Scientific Sessions, 2004, San Francisco,Annual Scientific Sessions Meeting Abstracts, 594 (2004). B29. Paul, M., T. Acil, M. Grude, P. Gerdes, G. Breithardt ve T. Wichter, Angiographic Characteristics and Potential Risk of Recurrent Ventricular Tachyarrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy, NASPE-Heart Rhythm 2004 Scientific Sessions, 2004, San Francisco,Annual Scientific Sessions Meeting Abstracts, 840 (2004). B30. Meyborg, M., J. Neumann, M. Paul, P. Boknik, T. Acil, P. Gerdes, M. Fobker ve T. Wichter, Biochemical analysis of impaired cardiac autonomic function in patients with idiopathic right ventricular outflow tract tachycardia, XXVI Congress of the European Society of Cardiology, Munich, 2004, Eur. Heart J., 25 (suppl), 67 (2004). B31. Grude, M., K.U. Jürgens, M. Paul, Chr. Bruch, T. Acil, J. Müller, R. Fischbach, G. Breithardt ve T. Wichter, Beurteilung linksventrikulärer Funktionsparameter mittels 16-11
12 Zeilen-Computertomographie: Untersuchung bei Patienten mit regionalen und globalen Kontraktionsstörungen unterschiedlicher Ätiologie und Ausprägung, 70. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Mannheim, 2004, Z. Kardiol., 93 (Supp 3), III/140 (2004). B32. Paul, M., T. Acil, M. Grude, P. Gerdes, A. Hellige ve T. Wichter T, Patienten mit arrhythmogener rechtsventrikulärer Kardiomyopathie: Zusammenhang zwischen klinischen Variablen und Arrhythmieausprägung, 70. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung, Mannheim, 2004, Z. Kardiol., 93 (Supp 3), III/394 (2004). B33. Wichter, T., F. Range, T. Acil, K.P. Schaefers, P. Kies, B. Brisse, G. Breithardt ve M. Schaefers, Impaired myocardial perfusion and perfusion reserve in persistent idiopathic atrial fibrillation, XXVII Congress of the European Society of Cardiology, Stockholm, 2005, Eur. Heart J., 26 (suppl), 730 (2005). B34. Sezgin, A.T., T. Katircibasi, A. Zumrutdal, G. Tekin, T. Kocum, A. Tekin, F. Yigit, T. Erol, T. Acil, N. Ermis, S. Demircan ve H. Muderrisoglu, Prevention of Contrast Nephropathy With Allopurinol. A Randomized Controlled Trial, Innovation in Intervention: i2 Summit 2006, Atlanta, 2006, J. Am. Coll. Cardiol., 47 (4), 19B (2006). B35. Yerdelen, D., T. Acil, B.K. Goksel, S. Karaca, M. Karatas ve M. Tan, Parasympathetic function in migraine and tension type headache, 10th Congress of the European Federation of Neurological Societies, Glasgow, 2006, Eur J Neurol, 13 (Suppl.), 252 (2006). B36. Colkesen, Y., T. Acil, Sezgin, A.T., Ozin, B., Tekin, A., Tekin, G., Muderrisoglu, H., The relation of mean platelet volume to paroxysmal atrial fibrillation: a predictive marker?, American Heart Association Scientific Sessions, 2007, Orlando, Circulation, 116 (Supp), II-438 (2007). 12
13 B37. Acil,T. Y.Colkesen, R. Turkoz, A.T. Sezgin, M. Baltali, G. Oner, S. Demircan, A.Yildirir, B. Ozin, H. Muderrisoglu, Usefulness of preoperative echocardiography in the prediction of postoperative atrial fibrillation following isolated coronary artery bypass grafting, 3rd Annual Congress on Update in Cardiology and Cardiovascular Surgery, Antalya, Turkey, Cardiovascular Drugs and Therapy, 21 (Supp), S54 (2007) B38. Colkesen, Y., T. Acil, A. Sezgin, S. Demircan, H. Muderrisoglu, Atherosclerotic risk factors in patients having acute ST elevation myocardial infarction under 35 years of age., 77th Congress of the European Atherosclerosis Society, Istanbul, Turkey, Atherosclerosis, 9/1 (Supp), 245 (2008). B39. Batur, M.K., T. Acil, G, Abali, Treatment of a giant coronary artery aneurysm involving the left anterior descending artery in a patient with Behcet's disease-percutaneous coronary intervention utilizing a covered stent as an alternative to coronary artery bypass grafting surgery, 6th Congress of Update in Cardiology and Cardiovascular Surgery in conjunction with 59th International Congress of the European Society for Cardiovascular Surgery, Izmir, Turkey, Int J Cardiol, 140, 86 (2010). Ulusal hakemli dergilerde yayınlanan makaleler D1. Aytemir, K., N. Özer, E. Atalar, E. Sade, T. Açıl, S. Aksöyek ve A. Oto, Is QT dispersion heart rate dependent? An electrophysiologic study, Türk Girişimsel Kardiyoloji Dergisi, 3, (1999). D2. Özer, N., K. Aytemir, A. Gürlek, E. Atalar, K. Övünç, S. Aksöyek, E. Sade, T. Açıl, N. Nazlı ve S. Kes, The evaluation of left ventricular diastolic function and myocardial performance index in asymptomatic type II diabetic patients, Türk Ekokardiyografi Dergisi, 2, (2000). 13
14 D3. Özer, N., K. Aytemir, E. Atalar, T. Açıl, S. Aksöyek, K. Övünç, L. Tokgözoğlu, F. Özmen ve S. Kes, Right-sided infective endocarditis after insertion of a temporary transvenous pacemaker: a case report, Türk Ekokardiyografi Dergisi, 2, (2000). D4. Atalar, E., T. Açıl, K. Aytemir, N. Özer, İ. Haznedaroğlu, S. Aksöyek, K. Övünç, H. Özkutlu, L. Tokgözoğlu, S. Kes, Ş. Kirazlı ve F. Özmen, Kararsız angina pektorisli hastalarda plazma homosistein düzeyi ve adezyon molekülleri arasındaki ilişki, Türk Girişimsel Kardiyoloji Dergisi, 5, (2001). D5. Atalar, E., K. Aytemir, T. Açıl, N. Özer, R. Çağrıkul, İ. Haznedaroğlu, G. Kuru, S. Aksöyek, K. Övünç, S. Kes ve F. Özmen, Serum solubl adezyon molekül düzeyleri ile koroner ateroskleroz şiddeti arasındaki ilişki, Türk Girişimsel Kardiyoloji Dergisi, 5, (2001). D6. Atalar, E., E. Özaslan, T. Açıl, K. Aytemir, N. Özer, A.R. Soylu, K. Övünç, S. Aksöyek, B. Sivri, H. Özkutlu ve F. Özmen, Kararlı angina pektorisi olan koroner arter hastalarında tanısal amaçlı yapılan üst gastrointestinal endoskopi sırasında sessiz iskemi ve aritmi riski, Türk Kardiyoloji Dergisi, 4, (2001). D7. Açıl, T., E. Schulze-Bahr, T. Wichter, G. Breithardt ve H. Wedekind, Ani kalp ölümü ve genetik yatkınlık, Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi, 2, (2004). D8. Açıl, T., Y. Çölkesen, N. Ermiş, A.T. Sezgin, M. Baltalı, Ö. Gülcan ve R. Türköz, Uzamış QRS süresinin sol ventrikül sistolik fonksiyon bozukluğu olan hastalarda izole koroner arter bypass cerrahisi sonrası gelişen kötü kardiyak olayların belirleyicisi olarak kullanılabilirliği, Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi, 4, (2006). D9. Çölkesen, Y., T. Açıl, S. Giray, O. Şen, A. Sezgin ve M. Baltalı, QTc intervali subaraknoid kanamanın kliniği (Yaşargil sınıflaması) ile pozitif korelasyon gösterir, Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi, 4, (2006). 14
15 D10. Colkesen, Y., T. Açıl, A. Tekin, G. Tekin, H. Muderrisoglu, Atherosclerotic risk factors in patients having acute ST elevation myocardial infarction under 35 years of age., IU Kardiyol Enst Derg, 6, (2007). D11. Colkesen, A.Y., T. Açıl, H. Muderrisoglu, A case-control study of risk factors that may contribute to the occurence paroxysmal atrial fibrillation., Turkiye Klinikleri J Cardiovasc Sci, 20, (2008). Ulusal bilimsel toplantılarda sunulan ve bildiri kitabında basılan bildiriler E1. Özer, N., K. Aytemir K, S. Aksöyek, T. Açıl, K. Övünç, L. Tokgözoğlu, G. Kabakcı, A. Oto, F. Özmen, E. Oram ve S. Kes, Koroner arter hastalığı gelişmesinde risk faktörü olarak total kan sayımı parametrelerinin incelenmesi, XIII. Ulusal Kardiyoloji Kongresi, 388, İzmir, E2. Atalar, E., E. Özaslan, A. Soylu, T. Açıl, G. Kabakçı, H. Özkutlu, B. Sivri ve F. Özmen, Koroner arter hastalarında üst gastrointestinal endoskopi sırasında sessiz iskemi ve aritmi sıklığı, XIV. Ulusal Kardiyoloji Kongresi, 152, Antalya, E3. Oto, A., M.K. Batur, A. Yıldırır, K. Övünç, G. Kabakçı, T. Açıl, K. Aytemir, H. Özkutlu, N. Nazlı ve S. Kes S, ICD takılan hastalarda antiaritmik tedavi, XIV. Ulusal Kardiyoloji Kongresi, 193, Antalya, E4. Batur, M.K., T. Açıl, K. Övünç, G. Kabakçı, A. Oto, H. Özkutlu, N. Nazlı, A. Oram, G. Gürsel, E. Oram ve S. Kes, İzole aort stenozunda gözlenen ciddi ventriküler takiaritmilerin nedeni ventriküler repolarizasyon heterojenitesi mi?, XIV. Ulusal Kardiyoloji Kongresi, 322, Antalya, E5. Batur, M.K., T. Açıl, R. Çağrıkul, G. Kabakçı, K. Övünç, F. Özmen, A. Oto, H. Özkutlu, N. Nazlı, A. Oram, G. Gürsel, E. Oram ve S. Kes, Akut miyokard infarktüsü sonrası risk 15
16 belirlenmesinde QT dispersiyon ne zaman değerlendirilmeli?, XIV. Ulusal Kardiyoloji Kongresi, 324, Antalya, E6. Atalar, E., F. Özmen, İ. Haznedaroğlu, K. Aytemir, G. Kabakçı, S. Aksöyek, K. Övünç, L. Tokgözoğlu, N. Özer, T. Açıl, Ş. Kirazlı, G. Gürsel ve A. Oto A, Kararlı angina pektorisli koroner arter hastalarında artmış trombosit aktivasyonu, XV. Ulusal Kardiyoloji Kongresi, 367, İzmir, E7. Aytemir, K., N. Özer, E. Atalar, E. Sade, T. Açıl, S. Aksöyek ve A. Oto, Elektrofizyolojik çalışma ile kalp hızının QT dispersiyon üzerindeki etkisinin araştırılması, XV. Ulusal Kardiyoloji Kongresi, 403, İzmir, E8. Açıl, T., H. Kılıç, E. Atalar, K. Aytemir, N. Özer, R. Çağrıkul, K. Övünç, S. Aksöyek, H. Özkutlu, N. Nazlı, S. Kes, A. Oto A ve F. Özmen F, PTCA esnasında tirofiban kullanımının QT dispersiyonu üzerine etkisi, XVI. Ulusal Kardiyoloji Kongresi, P22, Antalya, E9. Atalar, E., T. Açıl, K. Aytemir, A. Daver, N. Özer, İ. Haznedaroğlu, K. Övünç, S. Aksöyek, S. Kes ve F. Özmen F, Hiperkolestrolemik koroner arter hastalarında kısa süreli atorvastatin tedavisinin fibrinolitik sistem üzerine etkisi, XVI. Ulusal Kardiyoloji Kongresi, P76, Antalya, E10. Kabakçı, M.G., L. Yıldıran, M.K. Batur, R. Çağrıkul, Ö. Önalan, A. Yıldırır, T. Açıl, L. Tokgözoğlu, F. Özmen ve S. Kes, İnferiyor akut miyokard infarktüsünde yüzey elektrokardiyogramın infarktüsten sorumlu arteri ve sağ ventrikül tutulumunu belirlemedeki değeri: yeni bir kriter olarak Q dalgasının önemi var mı?, XVI. Ulusal Kardiyoloji Kongresi, P80, Antalya, E11. Aytemir, K., E. Atalar, T. Açıl, N. Özer, A. Daver, S. Aksöyek, K. Övünç, N. Nazlı, G. Gürsel, F. Özmen, A. Oto. S. Kes, Koroner arter hastalarında spontan miyokardiyal iskeminin QT dispersiyon üzerine etkisi, XVI. Ulusal Kardiyoloji Kongresi, P86, Antalya,
17 E12. Özmen, F., E. Atalar, K. Aytemir, N. Özer, A. Daver, T. Açıl, E. Akgül, S. Aksöyek, K. Övünç ve S. Kes, Kararsız angina pektorisli hastalarda perkütan revaskülarizasyonun P dalga dispersiyonu üzerine etkisi, XVI. Ulusal Kardiyoloji Kongresi, P88, Antalya, E13. Özmen, F., E. Atalar, K. Aytemir, A. Daver, T. Açıl, N. Özer, E. Akgül, S. Aksöyek, K. Övünç ve S. Kes, Kararsız angina pektorisli hastalarda artmış P dalga dispersiyonu, XVI. Ulusal Kardiyoloji Kongresi, P89, Antalya, E14. Atalar, E., K. Aytemir, T. Açıl, A. Daver, N. Özer, E. Akgül, S. Aksöyek, K. Övünç, S. Kes ve F. Özmen, Spontan miyokard iskemisinin P dalga dispersiyonu üzerine etkisi, XVI. Ulusal Kardiyoloji Kongresi, P117, Antalya, E15. Atalar, E., K. Aytemir, N. Başçıl, T. Açıl, N. Özer, R. Çağrıkul, K. Övünç, S. Aksöyek, S. Kes, A. Oto ve F. Özmen, Paroksismal atriyal fibrilasyon gelişen hipotiroidili hastalarda artmış P dalga dispersiyonu, XVI. Ulusal Kardiyoloji Kongresi, P142, Antalya, E16. Özer, N., K. Aytemir, S. Aksöyek, K. Övünç, E. Sade, E. Atalar, T. Açıl, B. Altun, Y. Erdem, N. Nazlı ve S. Kes, Sistemik hipertansiyona ve kronik böbrek yetmezliğine bağlı sol ventrikül hipertrofisi olan hastalarda sol ventrikül erken dolum pik akımının akım ilerleme hızına oranı, XVI. Ulusal Kardiyoloji Kongresi, P163, Antalya, E17. Açıl, T., K. Aytemir, E. Atalar, N. Özer, R. Çağrıkul, K. Övünç, S. Aksöyek, N. Nazlı, G. Gürsel, H. Özkutlu, S. Kes, A. Oto ve F. Özmen, Sendrom X li hastalarda QT dispersiyonunun tipik anjinal ağrı sırasında değerlendirilmesi, XVI. Ulusal Kardiyoloji Kongresi, P174, Antalya, E18. Özer, N., K. Aytemir, E. Atalar, E. Sade, A. Daver, R. Çağrıkul, T. Açıl, G. Kuru, K. Övünç, S. Aksöyek, H. Özkutlu, N. Nazlı, F. Özmen, S. Kes, Mitral darlıklı hastalarda P dalga dispersiyonu, sol ventrikül ve sol atriyal fonksiyonlar, XVI. Ulusal Kardiyoloji Kongresi, P296, Antalya,
18 E19. Atalar, E., K. Aytemir, T. Açıl, N. Özer, İ. Haznedaroğlu, K. Övünç, S. Aksöyek, G. Gürsel ve F. Özmen, Mitral kapak prolapsu olan hastalarda artmış fibrinolitik kapasite, XVI. Ulusal Kardiyoloji Kongresi, P300, Antalya, E20. Atalar, E., İ. Haznedaroğlu, K. Aytemir, N. Özer, T. Açıl, S. Aksöyek, K. Övünç ve F. Özmen, Kararsız angina pektorisli hastalarda artmış trombosit, lökosit ve endotel hücre aktivasyonu, XVI. Ulusal Kardiyoloji Kongresi, SB1, Antalya, E21. Atalar, E., K. Aytemir, İ. Haznedaroğlu, N. Özer, T. Açıl, K. Övünç, S. Aksöyek, S.Kes ve F.Özmen, İntrakoroner stent uygulamasından sonra aspirin ve tiklopidin tedavisi alan hastalarda trombosit ve lökosit deaktivasyonu, XVI. Ulusal Kardiyoloji Kongresi, SB36, Antalya, E22. Atalar, E., K. Aytemir, İ. Haznedaroğlu, T. Açıl, N. Özer, G. Kuru, S. Aksöyek, K. Övünç, F. Özmen, Serum solubl adezyon molekül düzeyleri ile koroner ateroskleroz şiddeti arasındaki ilişki, XVI. Ulusal Kardiyoloji Kongresi, SB64, Antalya, E23. Oto, A., M.K. Batur, A. Yıldırır, T. Açıl, O. Önalan, K. Aytemir, E. Atalar, L. Tokgözoğlu, G. Kabakçı, S. Aksöyek ve K. Övünç, Kalıcı kalp pili elektrod çıkarılmasında manuel, snare ve lazer kılıf yöntemlerinin kombine kullanımı, XVI. Ulusal Kardiyoloji Kongresi, SB109, Antalya, E24. Atalar, E., K. Aytemir, İ. Haznedaroğlu, N. Özer, T. Açıl, G. Kuru, S. Aksöyek, K. Övünç, H. Özkutlu, S. Kes, F. Özmen, Kararsız angina pektorisli hastalarda plazma homosistein düzeyi ve adezyon molekülleri arasındaki ilişki, XVI. Ulusal Kardiyoloji Kongresi, SB115, Antalya, E25. Atalar, E., T. Açıl, K. Aytemir, İ. Haznedaroğlu, N. Özer, K. Övünç, S. Aksöyek, A. Oto ve F. Özmen, Kronik atriyal fibrillasyonda hipofibrinoliz, XVI. Ulusal Kardiyoloji Kongresi, SB121, Antalya,
19 E26. Atalar, E., T. Açıl, K. Aytemir, İ. Haznedaroğlu, N. Özer, G. Kuru, S. Aksöyek, K. Övünç, N. Nazlı ve F. Özmen, Mitral darlığı olan hastalarda azalmış fibrinolitik kapasite, XVI. Ulusal Kardiyoloji Kongresi, SB121, Antalya, E27. Atalar, E., İ. Haznedaroğlu, T. Açıl, K. Aytemir, N. Özer, G. Kabakçı, K. Övünç, L. Tokgözoğlu, G. Gürsel, N. Nazlı, S. Aksöyek, F. Özmen ve S. Kes, Paroksismal supraventriküler taşikardi sırasında trombosit fonksiyonu, XVII. Ulusal Kardiyoloji Kongresi, P24, İzmir, E28. Atalar, E., İ. Haznedaroğlu, T. Açıl, K. Aytemir, N. Özer, G. Kabakçı, S. Aksöyek, K. Övünç, L. Tokgözoğlu, G. Gürsel, N. Nazlı, F. Özmen, S. Kes, Paroksismal atriyal fibrilasyonlu hastalarda artmış trombosit aktivasyonu, XVII. Ulusal Kardiyoloji Kongresi, P25, İzmir, E29. Alikaşifoğlu, M., L. Tokgözoğlu, E. Atalar, T. Açıl ve E. Tunçbilek, Tumor nekroz faktörü- alpha polimorfizmi dilate kardiyomiyopatili hastalarda ekokardiyografik parametreleri etkiliyor mu?, XVII. Ulusal Kardiyoloji Kongresi, SB107, İzmir, E30. Atalar, E., K. Aytemir, N. Özer, T. Açıl, İ. Haznedaroğlu, A. Daver, K. Övünç, S. Aksöyek, S. Kes, G. Gürsel, N. Nazlı, A. Oto ve F. Özmen, Hiperlipidemik koroner arter hastalarında kısa süreli atorvastatin tedavisi apoptozu azaltıyor ve lökosit deaktivasyonuna neden oluyor, XVII. Ulusal Kardiyoloji Kongresi, SB166, İzmir, E31. Çölkesen, Y., T. Açıl, M. Baltalı, A. Sezgin, G. Tekin, A. Tekin ve H. Müderrisoğlu, Stent kayıpları stent embolizasyonları, XXII. Ulusal Kardiyoloji Kongresi, P095, Antalya, E32. Sezgin, A.T., M.T. Katırcıbaşı, A. Tekin, G. Tekin, A. Zümrütdal, T. Koçum, T. Erol, F. Yiğit, T. Açıl, N. Ermiş, Ş. Demircan ve H. Müderrisoğlu, Allopurinol ile kontrast 19
20 nefropatinin önlenmesi: Randomize kontrollü bir çalışma, XXII. Ulusal Kardiyoloji Kongresi, P104, Antalya, E33. Açıl, T., Y. Çölkesen, N. Ermiş, A.T. Sezgin, M. Baltalı, Ö. Gülcan, R. Türköz, B. Özin ve H. Müderrisoğlu, Uzamış QRS süresinin sol ventrikül sistolik fonksiyon bozukluğu olan hastalarda izole koroner arter baypas cerrahisi sonrası gelişen kötü kardiyak olayların belirleyicisi olarak kullanılabilirliği, XXII. Ulusal Kardiyoloji Kongresi, SB144, Antalya, Diğer yayınlar Kitap bölümleri (Ulusal) F1. Açıl, T., B.Özin, Ani kalp ölümü, Kardiyolojide acil durumlar ve yoğun bakım (Editörler: A. Oto, H. Müderrisoğlu, K. Aytemir),s.18-26, Erkem Tıbbi Yayıncılık, Ankara (2008) (ISBN ) F2. Ertan, Ç., B.Özin, T.Açıl, Ritim bozuklukları, Kardiyolojide acil durumlar ve yoğun bakım (Editörler: A. Oto, H. Müderrisoğlu, K. Aytemir),s.27-52, Erkem Tıbbi Yayıncılık, Ankara (2008) (ISBN ) Uluslararası atıflar A2. Batur, M.K., T. Acil, O. Onalan, A. Yildirir, K. Ovunc, G. Kabakci, A. Oto, H. Ozkutlu, N. Nazli, G. Gursel ve S. Kes, Is ventricular repolarization heterogeneity a cause of serious ventricular tachyarrhythmias in aortic valve stenosis?, Clin. Cardiol., 23, (2000). (Atıf sayısı: 4) 1- Stilli, D., Berni, R., Bocchi, L., Zaniboni, M., Cacciani, F., Sgoifo, A., & Musso, E. (2004). Vulnerability to ventricular arrhthmias and heterogeneity of action potential duration in normal rats. Experimental physiology, 89(4),
Potential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
More informationAutomatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationBASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
More informationAdult Cardiac Surgery ICD9 to ICD10 Crosswalks
164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89
More informationCoronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
More informationNAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
More informationDiagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
More informationChristopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
More informationCardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes
More informationINTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
More informationTreating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
More informationPerioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
More informationTherapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
More informationCardiovascular diseases. pathology
Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and
More informationDiagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
More informationAntiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty
Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor
More informationHow To Understand What You Know
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
More informationCURRICULUM VITAE. Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology
CURRICULUM VITAE Personal Details Surname: Akbulut First Name: Mehmet Academic title/position: Professor Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology Research
More informationCHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart
More informationGENERAL HEART DISEASE KNOW THE FACTS
GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationAtrial Fibrillation The High Risk Obese Patient
Atrial Fibrillation The High Risk Obese Patient Frederick Schaller, D.O.,F.A.C.O.I. Professor and Vice Dean Touro University Nevada A 56 year old male with a history of hypertension and chronic stable
More informationVersion 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
More informationCancer and Heart/Stroke coverage
Cancer and Heart/Stroke coverage Assurant Supplemental Coverage» Pays cash right to you You never expect a life-threatening illness like cancer, heart attack or stroke. But if the unexpected happens to
More informationATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
More informationIschemia and Infarction
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to
More informationAtrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
More informationNCD for Lipids Testing
Applicable CPT Code(s): NCD for Lipids Testing 80061 Lipid panel 82465 Cholesterol, serum or whole blood, total 83700 Lipoprotein, blood; electrophoretic separation and quantitation 83701 Lipoprotein blood;
More informationCOVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
More information1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
More informationAtrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationYour Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
More informationAtrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
More informationHow to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
More informationCancer and Heart/Stroke coverage
Cancer and Heart/Stroke coverage Assurant Supplemental Coverage» Pays cash right to you You never expect a life-threatening illness like cancer, heart attack or stroke. But if the unexpected happens to
More informationAtrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
More informationAtrial Fibrillation and Heart Failure: A Cause or a Consequence
Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationSecondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
More informationCARDIAC CARE. Giving you every advantage
CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The
More informationCardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:
More informationCardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
More informationMedical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
More informationHow should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
More informationLIMITED BENEFIT HEALTH COVERAGE FOR SPECIFIED CRITICAL ILLNESS. OUTLINE OF COVERAGE (Applicable to Policy Form CI-1.0-NC)
COLONIAL LIFE & ACCIDENT INSURANCE COMPANY 1200 Colonial Life Boulevard, P.O. Box 1365, Columbia, South Carolina 29202 1.800.325.4368 www.coloniallife.com A Stock Company LIMITED BENEFIT HEALTH COVERAGE
More informationPHC4 35 Diseases, Procedures, and Medical Conditions for which Laboratory Data is Required Effective 10/1/2015
PHC4 35 Diseases, Procedures, and Medical Conditions for which Laboratory Data is Required Effective 10/1/2015 Laboratory data is to be submitted for discharges in the following conditions: 1. Heart Attack
More informationPHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
More informationThe largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
More informationCilostazol versus Clopidogrel after Coronary Stenting
Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background
More informationLIPID PANEL CHOLESTEROL LIPOPROTEIN, ELECTROPHORETIC SEPARATION LIPOPROTEIN, DIRECT MEASUREMENT (HDL) LDL DIRECT TRIGLYCERIDES
Test Code Test Name CPT CHOL Cholesterol, Serum 82465 HDL HDL, (High Density Lipoprotein) 83718 TRIG Triglycerides, Serum 84478 FTRIG Triglycerides (Fluid) 84478 LIPID Lipid Panel 80061 LDL LDL (Low Density
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationAtrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
More informationImplantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population. Carel Jan Willem Borleffs
Implantable Cardioverter Defibrillator Treatment: Benefits and Pitfalls in the Currently Indicated Population Carel Jan Willem Borleffs The studies described in this thesis were performed at the Department
More informationANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head
ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION
More informationCardiovascular Disease and Maternal Mortality what do we know and what are the key questions?
Cardiovascular Disease and Maternal Mortality what do we know and what are the key questions? AFSHAN HAMEED, MD, FACOG, FACC Associate Clinical Professor Maternal Fetal Medicine and Cardiology University
More informationElenco dei periodici elettronici in Ovid Full text
Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders
More informationA randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation
A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation Gabriel Sayer Lay Abstract: Atrial fibrillation is a common form of irregular,
More informationManaging the Patient with Atrial Fibrillation
Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION
More informationMedical Surgical Nursing (Elsevier)
1 of 6 I. The Musculoskeletal System Medical Surgical Nursing (Elsevier) 1. Med/Surg: Musculoskeletal System: The Comprehensive Health History 2. Med/Surg: Musculoskeletal System: A Nursing Approach to
More informationAppendix. Costing Case Samples for OOHCA
Appendix Costing Case Samples for OOHCA The patient (ICD-1) Treatment Codes (OPCS 4) Patient 27 Admitted to ICU following percutaneous cardiac intervention (PCI) with 2 drugeluting stents following a VF
More informationAnticoagulants in Atrial Fibrillation
Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives
More informationFort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges
NAME Fort Hamilton Hospital Specialty: Cardiology Department of Medicine Delineation of Privileges GENERAL CARDIOLOGY Required Qualifications for General Cardiology Education/Training/Experience Must have
More informationTerm Critical Illness Insurance
Term Critical Illness Insurance PRODUCT GUIDE 5368-01A-JUL14 ASSUMPTION LIFE This document is a summary of the various features of Assumption Life's products. It is neither a contract nor an insurance
More informationAtrial Fibrillation in the ICU: Attempting to defend 4 controversial statements
Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary
More informationCardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC The Federal Motor Carrier Safety Administration (FMCSA) administers the Federal Motor Carrier Safety Regulations (FMCSRs)
More informationMEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE
DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:
More informationRISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department
RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital
More informationTABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)
Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly
More informationACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
More informationDuration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
More informationYour Guide to Express Critical Illness Insurance Definitions
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
More informationAcquired Heart Disease: Prevention and Treatment
Acquired Heart Disease: Prevention and Treatment Prevention and Treatment Sharon L. Roble, MD Assistant Professor Adult Congenital Heart Program The Ohio State University/Nationwide Children s Hospital
More informationHot Line Session at European Society of Cardiology (ESC) Congress 2014:
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Once-Daily
More informationAtrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
More informationMEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: 8.01.14 CATEGORY: Therapy/ Rehabilitation
MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
More informationUNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA
SYSTEMATIC PATHOLOGY I IIIYear Scientific Field DISCIPLINE TUTOR Systematic Pathology I MED/21 MED/10 Thoracic Surgery Respiratory Diseases Tommaso Claudio Mineo Paola Rogliani MED/10 Respiratory Diseases
More informationATRIAL FIBRILLATION: Scope of the Problem. October 2015
ATRIAL FIBRILLATION: Scope of the Problem October 2015 Purpose of the Presentation Review the worldwide incidence and prognosis associated with atrial fibrillation (AF) Identify the types of AF, clinical
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationAdvanced Specialist Training (AST) Programme in Cardiology
I. Definition Cardiology is a medical subspecialty concerned with the prevention, diagnosis, management, and rehabilitation of patients with diseases of the cardiovascular system. A cardiologist is a specialist
More informationTHE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
More informationCARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN
HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationHow do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
More informationSurgeons Role in Atrial Fibrillation
Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)
More informationSUTTER MEDICAL CENTER, SACRAMENTO Department of Cardiovascular Disease Cardiology - Delineation of Privileges
INITIAL: [ ] RENEWED: [ ] DATE: ADDITIONAL: [ ] Privileges are granted for Sutter General Hospital, Sutter Memorial Hospital, Sutter Center for Psychiatry, Sutter Oaks Midtown and the Capitol Pavilion
More informationElectrocardiographic Issues in Williams Syndrome
Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital
More informationObjectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
More informationESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease
Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening
More informationBOLETIN BIBLIOGRAFICO BIBLIOTECA MEDICA-HCG JUNIO 2014
BOLETIN BIBLIOGRAFICO BIBLIOTECA MEDICA-HCG JUNIO 2014 Am J Clin Pathol 1. 2013 Statement on Human Papillomavirus DNA Test Utilization. AJCP 141 (4): 459-461, abr. 2014 2. Pathology Consultation on Electronic
More informationCHESHIRE EAST COUNCIL DRIVER MEDICAL
BLOCK LETTERS PLEASE: CHESHIRE EAST COUNCIL DRIVER MEDICAL FULL NAME OF APPLICANT:.. DATE OF BIRTH.... ADDRESS:............. POST CODE... This certificate, which must be completed by a Registered Medical
More informationType II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
More informationCORONARY ARTERY DISEASE ALTERS VENTRICULAR REPOLARIZATION DYNAMICS IN TYPE 2 DIABETES
b Source of Acquisition NASA Johnson Space Center I. CORONARY ARTERY DISEASE ALTERS VENTRICULAR REPOLARIZATION DYNAMICS IN TYPE 2 DIABETES Bojan Vrtovec, MD, PhD; Matjaz Sinkovec, MD, PhD; Vito Starc,
More informationAddendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter
22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release
More informationDarlene Langhoff St. Thomas More High Ron Gerrits MSOE
Darlene Langhoff St. Thomas More High Ron Gerrits MSOE Investigating the Scene DNA analysis The Findings Crime scene is set up (optional power point ) Tip: Set up crime scene and have students take photos
More informationThrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003
Thrombophilia Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003 Thrombophilia Hereditary and acquired risk factors for thrombosis Venous thromboembolism Arterial thromboembolism
More informationCARDIOLOGY Delineation of Privileges
CARDIOLOGY Delineation of Privileges APPLICANT: INITIAL APPOINTMENT REQUIREMENTS: BASIC EDUCATION: M.D. or D.O. from an accredited school of medicine or osteopathy. Successful completion of an ACGME or
More informationHYPERTROPHIC CARDIOMYOPATHY
HYPERTROPHIC CARDIOMYOPATHY Most often diagnosed during infancy or adolescence, hypertrophic cardiomyopathy (HCM) is the second most common form of heart muscle disease, is usually genetically transmitted,
More information